New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful push for the Covid-19 vaccine.
Cancer vaccine research at the biotech company Moderna in Cambridge, Mass., which reported in August promising results that a melanoma vaccine increased the time before cancers recurred and increased the time before the cancers spread.
Login
